DD153375A5 - Verfahren zur herstellung eines festen solvats aus syn-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino]acetamido-3-acetoxymethyl-3-cephem-4-carbonsaeure und einem alicyclischen ether - Google Patents

Verfahren zur herstellung eines festen solvats aus syn-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino]acetamido-3-acetoxymethyl-3-cephem-4-carbonsaeure und einem alicyclischen ether Download PDF

Info

Publication number
DD153375A5
DD153375A5 DD80224408A DD22440880A DD153375A5 DD 153375 A5 DD153375 A5 DD 153375A5 DD 80224408 A DD80224408 A DD 80224408A DD 22440880 A DD22440880 A DD 22440880A DD 153375 A5 DD153375 A5 DD 153375A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
solvate
acid
mixture
reaction mixture
Prior art date
Application number
DD80224408A
Other languages
German (de)
English (en)
Inventor
Billy G Jackson
Donna N Gardner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD153375A5 publication Critical patent/DD153375A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD80224408A 1979-10-09 1980-10-08 Verfahren zur herstellung eines festen solvats aus syn-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino]acetamido-3-acetoxymethyl-3-cephem-4-carbonsaeure und einem alicyclischen ether DD153375A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/082,822 US4252951A (en) 1979-10-09 1979-10-09 Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid

Publications (1)

Publication Number Publication Date
DD153375A5 true DD153375A5 (de) 1982-01-06

Family

ID=22173679

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80224408A DD153375A5 (de) 1979-10-09 1980-10-08 Verfahren zur herstellung eines festen solvats aus syn-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino]acetamido-3-acetoxymethyl-3-cephem-4-carbonsaeure und einem alicyclischen ether

Country Status (27)

Country Link
US (1) US4252951A (fr)
EP (1) EP0027050B1 (fr)
JP (1) JPS5661388A (fr)
KR (1) KR840000866B1 (fr)
AT (1) AT369008B (fr)
AU (1) AU6306180A (fr)
BE (1) BE885569A (fr)
CA (1) CA1146539A (fr)
CH (1) CH647523A5 (fr)
CS (1) CS215142B2 (fr)
DD (1) DD153375A5 (fr)
DE (1) DE3065181D1 (fr)
DK (1) DK424680A (fr)
ES (1) ES495753A0 (fr)
FI (1) FI803200L (fr)
FR (1) FR2467211A1 (fr)
GB (1) GB2059966B (fr)
GR (1) GR70219B (fr)
HU (1) HU183230B (fr)
IE (1) IE50390B1 (fr)
IL (1) IL61227A (fr)
IT (1) IT1132926B (fr)
PH (1) PH15023A (fr)
PT (1) PT71886B (fr)
RO (1) RO80664B (fr)
YU (1) YU256480A (fr)
ZA (1) ZA806192B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588086A (ja) * 1981-07-07 1983-01-18 Takeda Chem Ind Ltd セフアロスポリン溶媒和物およびその製造法
US4426528A (en) 1982-04-01 1984-01-17 Eli Lilly And Company Purification of syn-(2-aminothiazol-4-yl)methoxyimino)acetic acid
JPH08831B2 (ja) * 1985-09-20 1996-01-10 富山化学工業株式会社 セファロスポリンの精製法
JPH07116200B2 (ja) * 1985-09-20 1995-12-13 富山化学工業株式会社 セファロスポリンの製造方法
USD404431S (en) 1997-06-30 1999-01-19 Hilco Corporation Gumball dispenser
WO2000059851A1 (fr) * 1999-04-06 2000-10-12 Sepracor Inc. Derives de la venlafaxine et leurs procedes de preparation et utilisation
EP1219607B1 (fr) * 1999-09-02 2011-04-06 Shionogi & Co., Ltd. Inhibiteur d'integrase contenant des derives heterocycliques aromatiques
CA2284459C (fr) 1999-10-04 2012-12-11 Neokimia Inc. Synthese combinatoire de bibliotheques de composes macrocycliques utiles pour la decouverte de medicaments
WO2001051454A1 (fr) * 2000-01-13 2001-07-19 Emisphere Technologies, Inc. Composes et compositions permettant d"administrer des principes actifs
CN1522148A (zh) * 2001-03-08 2004-08-18 ��Ϧ�������ݴ�ѧ���»� 作为抗感染药的表面两亲聚合物
MXPA04001831A (es) * 2001-08-29 2004-07-08 Neose Technologies Inc Nuevos derivados sinteticos de gangliosidos y composiciones de los mismos.
CA2498944C (fr) * 2002-09-19 2011-05-17 Yasushi Kohno Derives d'aminoalcool, sels connexes et agents immunosuppresseurs
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
CN102432511B (zh) * 2003-03-17 2016-06-08 宾夕法尼亚州大学理事会 表面两亲聚合物和低聚物及其应用
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US20050203184A1 (en) 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
CN103012213A (zh) * 2004-01-23 2013-04-03 宾夕法尼亚州大学理事会 表面两亲性聚芳基和聚芳基炔基聚合物和低聚物及其用途
ZA200609924B (en) * 2004-05-06 2008-12-31 Univ California Substituted enaminones, their derivatives and uses thereof
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
AU2006218805A1 (en) * 2005-02-25 2006-09-08 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
US7893304B2 (en) * 2005-02-28 2011-02-22 Meiji Dairies Corporation Hydroquinone long-chain derivatives and/or phenoxy long-chain derivatives, and pharmaceuticals comprising the same
JP5484728B2 (ja) * 2005-08-10 2014-05-07 ジョンズ ホプキンス ユニバーシティ 抗寄生虫治療薬および抗癌治療薬ならびにリジン特異的デメチラーゼ阻害物質として有用なポリアミン類
CA2619402C (fr) * 2005-08-15 2015-02-03 Boehringer Ingelheim International Gmbh Procede de production de betamimetiques
US8592433B2 (en) * 2005-10-28 2013-11-26 Advait Nagle Compounds and compositions as protein kinase inhibitors
EP1954259A2 (fr) * 2005-11-29 2008-08-13 Hammersmith Imanet, Ltd Derives d'amidines pour l'imagerie in vivo
ES2288107B1 (es) * 2006-01-27 2008-11-01 Fundacion Imabis Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanita Derivados aciclicos saturados e insaturados de cadena larga de sulfamidas como activadores especificos de receptores ppar-alfa.
FR2902999B1 (fr) * 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
US20090075935A1 (en) * 2006-07-03 2009-03-19 L'oreal Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use
AU2007334428B2 (en) * 2006-12-14 2014-05-29 Teva Pharmaceutical Industries, Ltd. Crystalline solid rasagiline base
CN101730706B (zh) 2007-05-11 2015-04-15 生物科技研究有限公司 具有神经保护和增强记忆活性的受体拮抗剂
US7696383B2 (en) * 2007-06-26 2010-04-13 Solvay Pharmaceuticals B.V. N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
FR2920000B1 (fr) * 2007-08-13 2010-01-29 Oreal Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement
JP5439381B2 (ja) * 2007-10-19 2014-03-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ γ−セクレターゼのピペリジニル及びピペラジニル調節物質
EA018862B1 (ru) * 2007-10-19 2013-11-29 Янссен Фармацевтика, Н.В. МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
WO2009052334A1 (fr) * 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Modulateurs liés au carbone de la γ-sécrétase
EP2093207A1 (fr) * 2008-02-06 2009-08-26 Julius-Maximilians-Universität Würzburg Composés anti-infectieux et anti-tumoraux isolés de lianes tropicales
US8063249B1 (en) * 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
US20100056475A1 (en) * 2008-08-06 2010-03-04 Alexander Chucholowski Cyclodextrin conjugates
EA201100654A1 (ru) 2008-10-22 2012-01-30 Акусела, Инк. Соединения для лечения офтальмологических заболеваний и расстройств
FR2940610B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
WO2010111530A1 (fr) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipides en tant que traitement de maladies
US9187482B2 (en) 2009-05-14 2015-11-17 Millennium Pharmaceuticals, Inc. Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
US8962639B2 (en) * 2009-05-29 2015-02-24 Abbvie Inc. Potassium channel modulators
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
US8609674B2 (en) 2010-11-16 2013-12-17 Abbvie Inc. Potassium channel modulators
MX365525B (es) * 2011-09-06 2019-06-06 Curna Inc Compuestos que regulan la expresión de subunidades alfa de canales de sodio regulados por voltaje en enfermedades relacionadas con epilepsia mioclónica severa de la infancia.
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
DE2760484C2 (fr) 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp

Also Published As

Publication number Publication date
IT1132926B (it) 1986-07-09
EP0027050B1 (fr) 1983-10-05
DE3065181D1 (en) 1983-11-10
KR840000866B1 (ko) 1984-06-20
IT8025200A0 (it) 1980-10-08
DK424680A (da) 1981-04-10
YU256480A (en) 1983-02-28
ATA498080A (de) 1982-04-15
CA1146539A (fr) 1983-05-17
AU6306180A (en) 1981-04-16
FR2467211A1 (fr) 1981-04-17
CH647523A5 (fr) 1985-01-31
JPS5661388A (en) 1981-05-26
EP0027050A1 (fr) 1981-04-15
HU183230B (en) 1984-04-28
GB2059966B (en) 1983-09-01
PT71886A (en) 1980-11-01
BE885569A (fr) 1981-04-08
ES8201166A1 (es) 1981-12-01
ZA806192B (en) 1982-05-26
FR2467211B1 (fr) 1983-06-10
KR830004314A (ko) 1983-07-09
PH15023A (en) 1982-05-13
IL61227A0 (en) 1980-12-31
IL61227A (en) 1983-07-31
ES495753A0 (es) 1981-12-01
IE802086L (en) 1981-04-09
GB2059966A (en) 1981-04-29
AT369008B (de) 1982-11-25
CS215142B2 (en) 1982-07-30
FI803200A7 (fi) 1981-04-10
RO80664B (ro) 1983-02-28
US4252951A (en) 1981-02-24
PT71886B (en) 1981-08-13
FI803200L (fi) 1981-04-10
RO80664A (fr) 1983-02-15
GR70219B (fr) 1982-08-31
IE50390B1 (en) 1986-04-16

Similar Documents

Publication Publication Date Title
DD153375A5 (de) Verfahren zur herstellung eines festen solvats aus syn-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino]acetamido-3-acetoxymethyl-3-cephem-4-carbonsaeure und einem alicyclischen ether
DE69313869T2 (de) Herstellung von Clavulansäure via Tert.-Octylamin
DE69721290T2 (de) Kristalline substanz von pivoxilcefditoren und verfahren zu ihrer herstellung
DE3427859C2 (de) Verfahren zur Herstellung von Natrium-Cefuroxim
DE2001017A1 (de) 3,4-Dihydro-1,2,3-oxathiazin-4-one,ihre Herstellung und Verwendung
DE2842358C2 (fr)
DE4307422A1 (de) Verfahren zur Herstellung von Clavulansäuresalzen
DE1670600A1 (de) Verfahren zur Herstellung neuer Cephalosporinverbindungen mit antibiotischer Wirksamkeit
DE2953969C2 (fr)
DE69508962T2 (de) Diclavulanat-salze mit diaminoether und verfahren zu deren herstellung
DE3852560T2 (de) Kristallines Cefadroxil und Verfahren zu dessen Herstellung.
DE2225149C2 (de) Oxofurylesterderivate der 6-(ą-Aminophenylacetamido)penicillansäure, Verfahren zu deren Herstellung und ihre Verwendung
DE3005564C2 (fr)
DE3432984A1 (de) Chemisches verfahren
DE69219582T2 (de) Neue verbindung und trennungsreagenz
DE2423048C2 (de) Verfahren zur Herstellung eines kristallinen Solvats eines Alkali- oder Erdalkalimetallsalzes von Amoxicillin mit einem Amid
DE3004700C2 (de) Verfahren zur Herstellung von Tryptaminderivaten
EP0282531B1 (fr) Forme cristalline stable d'un produit intermediaire de la cephalosporine
DE69306694T2 (de) Kristalle von Hydroxyphenylpropionsäure-ester und ihre Herstellung
DD140048A5 (de) Verfahren zur herstellung von 4"-desoxy-4"-amino-erythromycin-a-verbindungen
DE69030399T2 (de) Verfahren zur Herstellung von 3-Exomethylencephamsulfoxydderivate und Zwischenverbindungen
DE2519533A1 (de) Vincadiolin und verfahren zu seiner gewinnung
DE2539027B2 (de) Verfahren zur reinigung von diaminomaleinsaeuredinitril
EP0001797B1 (fr) Procédé de séparation de céphalosporine C, ses sels et ses dérivés, à partir de milieux et de filtrats de culture
DE2056538A1 (de) In organischen Losungsmitteln los hches Derivat von Cephalosporin C und seine Herstellung aus Cephalosporin C